ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis.

In the search for safe vaccine candidates against tuberculosis (TB), subunit vaccines including peptide-based candidates deserve consideration. However, an important requirement for such vaccine candidates is their promiscuous presentation to Th1 cells mediating protective immunity against TB, i.e. Th1 cells secreting IFN-gamma. The aim of the present study was to identify promiscuous Th1 cell epitopes of three major secreted antigens of Mycobacterium tuberculosis, i.e. ESAT-6, CFP10 and MPT70 by using a virtual matrix-based prediction program (ProPred) for peptide binding to 51 HLA-DR alleles. The ProPred analysis of these proteins was performed using the server (http:www.imtech.res.in/raghava/ProPed/). The peptides predicted to bind > 50% HLA-DR alleles included in the ProPred were considered promiscuous for binding predictions. Based on this criteria, one region in ESAT-6 (aa 69-77), two regions in CFP10 (aa 55-66 and aa 76-84) and four regions in MPT70 (aa 1-11, aa 81-95, aa 124-140 and aa 182-191) were considered promiscuous HLA-DR binders. The experimental evaluation of these regions, by using overlapping synthetic peptides for presentation to T-cells, confirmed the promiscuous nature of peptides covering the regions aa 69-77, aa 76-84 and aa 182-191 of ESAT-6, CFP10 and MPT70, respectively. These results demonstrate that the ProPred analysis can facilitate the selection of promiscuous peptides recognized by Th1 cells, and thus it can be useful in the identification of peptide-based vaccine candidates against TB.

[1]  T. Eguale,et al.  Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. , 1999, The Journal of infectious diseases.

[2]  R. G. Hewinson,et al.  Recognition of Mycobacterial Epitopes by T Cells across Mammalian Species and Use of a Program That Predicts Human HLA-DR Binding Peptides To Predict Bovine Epitopes , 2003, Infection and Immunity.

[3]  A. D. De Groot,et al.  An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. , 1997, AIDS research and human retroviruses.

[4]  Matteo Bellone,et al.  Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11 , 1999, The Journal of experimental medicine.

[5]  Young,et al.  Identification of a Novel Protein Antigen Encoded by a Mycobacterium tuberculosis‐Specific RD1 Region Gene , 1999, Scandinavian journal of immunology.

[6]  Suhail Ahmad,et al.  Construction of a modified vector for efficient purification of recombinant Mycobacterium tuberculosis proteins expressed in Escherichia coli. , 2003, Protein expression and purification.

[7]  Z. Nagy,et al.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.

[8]  R. Al-Attiyah,et al.  Tuberculosis: looking beyond BCG vaccines. , 2003, Journal of postgraduate medicine.

[9]  Michael A. Gonzalez,et al.  From genome to vaccine: in silico predictions, ex vivo verification. , 2001, Vaccine.

[10]  K. Lundin,et al.  Isolation of recombinant phage clones expressing mycobacterial T cell antigens by screening a recombinant DNA library with human CD4+ Th1 clones. , 1998, FEMS immunology and medical microbiology.

[11]  Harald G. Wiker,et al.  Synthetic Peptides Identify Promiscuous Human Th1 Cell Epitopes of the Secreted Mycobacterial Antigen MPB70 , 2003, Infection and Immunity.

[12]  U. Şahin,et al.  Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.

[13]  R. Al-Attiyah,et al.  Computer‐Assisted Prediction of HLA‐DR Binding and Experimental Analysis for Human Promiscuous Th1‐Cell Peptides in the 24 kDa Secreted Lipoprotein (LppX) of Mycobacterium tuberculosis , 2004, Scandinavian journal of immunology.

[14]  T. Ottenhoff,et al.  Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. , 2002, The Journal of infectious diseases.

[15]  P. Andersen,et al.  Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT‐6 antigen , 2000, European journal of immunology.

[16]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[17]  A. Mustafa.  Development of new vaccines and diagnostic reagents against tuberculosis. , 2002, Molecular immunology.

[18]  F. Sinigaglia,et al.  HLA class II peptide binding specificity and autoimmunity. , 1997, Advances in immunology.

[19]  Andersen,et al.  Comparison of Antigen‐Specific T‐Cell Responses of Tuberculosis Patients using Complex or Single Antigens of Mycobacterium tuberculosis , 1998, Scandinavian journal of immunology.

[20]  Adeeba Kamarulzaman,et al.  AIDS Res Hum Retroviruses , 2006 .

[21]  Fabio Grassi,et al.  Identification of a Promiscuous T-Cell Epitope in Mycobacterium tuberculosis Mce Proteins , 2002, Infection and Immunity.

[22]  T. Ottenhoff,et al.  Antigenic Equivalence of Human T-Cell Responses toMycobacterium tuberculosis-Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic Peptides , 2000, Infection and Immunity.

[23]  P. Andersen,et al.  Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. , 2003, FEMS immunology and medical microbiology.

[24]  K. Lundin,et al.  Identification and HLA Restriction of Naturally Derived Th1-Cell Epitopes from the Secreted Mycobacterium tuberculosisAntigen 85B Recognized by Antigen-Specific Human CD4+T-Cell Lines , 2000, Infection and Immunity.

[25]  F. Oftung,et al.  Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  D. Enarson,et al.  Epidemiology of tuberculosis in Kuwait from 1965 to 1999. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[27]  K. Lundin,et al.  Cross‐reactive epitopes and HLA‐restriction elements in human T cell recognition of the Mycobacterium leprae 18‐kD heat shock protein , 2000, Clinical and experimental immunology.

[28]  M. Hagmann,et al.  Computers Aid Vaccine Design , 2000, Science.

[29]  H. Vordermeier,et al.  Use of Synthetic Peptides Derived from the Antigens ESAT-6 and CFP-10 for Differential Diagnosis of Bovine Tuberculosis in Cattle , 2001, Clinical Diagnostic Laboratory Immunology.

[30]  E. Agger,et al.  Tuberculosis subunit vaccine development: on the role of interferon-gamma. , 2001, Vaccine.

[31]  Gajendra P. S. Raghava,et al.  ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..

[32]  A. Mustafa,et al.  HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. , 2000, Human immunology.

[33]  A. Mustafa.  Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w. , 1988, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[34]  K. Lundin,et al.  Identification of Promiscuous Epitopes from the Mycobacterial 65-Kilodalton Heat Shock Protein Recognized by Human CD4+ T Cells of the Mycobacterium lepraeMemory Repertoire , 1999, Infection and Immunity.

[35]  A. Mustafa.  Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. , 2001, Current pharmaceutical biotechnology.

[36]  F. Oftung,et al.  Human Th1 Cell Lines Recognize the Mycobacterium tuberculosis ESAT‐6 Antigen and its Peptides in Association with Frequently Expressed HLA Class II Molecules , 2003, Scandinavian journal of immunology.

[37]  H. Vordermeier,et al.  Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle , 2002, Clinical and experimental immunology.